Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
ICOTYDE (ICOTROKINRA HYDROCHLORIDE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
ICOTYDE
NDA
Get alerts
ICOTROKINRA HYDROCHLORIDE | N220149 | JANSSEN BIOTECH INC
1 strength
3 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Patent Timeline
3 unique patents, 1 exclusivity by expiration date
Active (3)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
Today
11845808
Jan. 14, 2041
11939361
Nov. 19, 2041
12552836
Jul. 12, 2039
NCE
Mar. 17, 2031
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 200MG BASE
RLD
3 patents
1 exclusivity
▴
TABLET;ORAL | Approved: Mar 17, 2026
Patents (3)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
11845808
Jan 14, 2041
—
Yes
—
U-4447
—
11939361
Nov 19, 2041
—
—
Yes
U-4447
—
12552836
Jul 12, 2039
—
Yes
Yes
—
—
Exclusivities (1)
Code
Date
Status
NCE
Mar 17, 2031
Active